Stock · A · Healthcare

Agilent Technologies Inc

United States · Large Cap · listed since 1999 · Revenue 12 mo. $7.4B

Price as of 11/06/2026

StockScorer score
4.5
of 10 5 of 11 points Low Match To the score
Price
$174.76
1 Y +8.9%
Market cap
$50.1B
Phase
Mature
core business profitable, revenue barely moving
Revenue +0.5% a year (3 years)EBIT margin 21.3%Payout 46.0% of operating cash flow

Agilent Technologies, Inc. provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide.

moreless

Agilent Technologies, Inc. provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide. The company operates through three segments: Life Sciences and Diagnostics Markets, Agilent CrossLab, and Applied Markets. The Life Sciences and Diagnostics Markets segment offers liquid chromatography systems and components; and liquid chromatography mass spectrometry systems. This segment is also involved in the genomics, contract development and manufacturing organization, pathology, companion diagnostics, and biomolecular analysis businesses. The Agilent CrossLab segment provides various services, including repairs, parts, maintenance, installations, training, compliance support, software as a service, asset management, consulting, and other custom services. This segment also offers consumables, including gas chromatography and liquid chromatography columns, sample preparation products, custom chemistries, and various laboratory supplies; software and informatics solutions comprising software for instrument control, data acquisition, data analysis, secure storage of results, and laboratory information and workflow management; and OpenLab laboratory software, an open software platform that enables customers to capture, analyze, and share scientific data throughout the lab and across the enterprise. In addition, it provides automated sample preparation solutions, such as liquid handling, plate management, consumables, and scheduling software. The Applied Markets segment offers products in the areas of gas chromatography, mass spectrometry, spectroscopy, vacuum technology, and remarketed instruments. It markets its products through direct sales, distributors, resellers, manufacturer's representatives, and electronic commerce. Agilent Technologies, Inc. was incorporated in 1999 and is headquartered in Santa Clara, California.

Original text from the data provider

Summary

Agilent Technologies Inc is around the middle of the Healthcare sector overall

53.0 of 100

Mean of the six area values. Each area value is the mean of the stock's ranks among the companies in its sector. 50 is the middle of the sector, not a share of companies beaten.

Analysis

What the price requires

The price requires 19.0% FCF growth a year, more than achieved over the last 5 and 10 years.

If free cash flow stays at €1B (2025), it supports €11.5B. The remaining €33.5B of the market value assume it grows 19.0% a year for 10 years and not at all afterwards.

Required FCF growth per year

19.0%

no growth afterwards

Market value breakdown€45B market value, price as of 11/06/2026

€11.5B without growth
€33.5B priced-in growth
  • 5 yrs achieved 8.6%
  • 10 yrs achieved 10.8%
  • priced in 19.0%

Valuation against its own history

Price to operating cash flow 30.7×, above its usual range.

Middle half of 20 quarters: 22.2× to 27.4×, median 24.4×.

Measures only against its own past, not against what the company is worth. Price as of 11/06/2026.

3 signs support the expectation, 1 speaks against it.

What supports it

with respect to the priced-in expectation

  • High, stable gross margin median 53.9%, range 4.0 pp (10 years)
  • Low capital needs capex median 3.8% of revenue (10 years)
  • Steady FCF margin at least 14.9%, range 6.7 pp (10 years)

What speaks against it

with respect to the priced-in expectation

  • Expectation above the company's own record priced in 19.0%, achieved at most 10.8%

Since the last quarter

Q2 → Q3 2026

Mostly better than the previous quarter: 2 of 3 changes for the better.

  • FCF, 12 mo.$1.3B → $1.4B+14.3%better
  • FCF margin17.4% → 19.5%+2.1 ppbetter
  • Net debt$1.5B → $2.2B+41.5%worse

5 more unchanged: Revenue, 12 mo., Gross margin, EBIT margin, Shares outstanding, Return on equity

Derivation

How the sector comparison is derived

Each area value is the average of its metrics' ranks within the sector (0 to 100, 50 is the middle). For metrics where lower is better, the rank is mirrored. The overall value is the average of the area values.

Price as of 11/06/2026.

Profitability58.1around the middleEarns about as much as the sector.
MetricStockSector medianPosition in sector
Return on equity19.33%11.52%Rank 77
Return on capital (Greenblatt)34.64%32.55%Rank 53
EBIT margin21.29%18.31%Rank 67
FCF margin16.58%14.12%Rank 57
Gross margin52.43%60.99%Rank 37
Growth57.8around the middleGrows about as fast as the sector.
MetricStockSector medianPosition in sector
Revenue growth, 1 year6.73%8.04%Rank 44
Earnings growth, 3 years per year3.15%5.44%Rank 47
Earnings growth, 5 years per year14.77%7.00%Rank 68
Sustainable growth (ROE × retained earnings)5.86%3.66%Rank 72
Valuation28.3below the middleValued higher than the sector: EV/EBIT 34.93, sector 21.73.
MetricStockSector medianPosition in sector
Earnings yield2.63%2.90%Rank 42
FCF yield2.30%3.63%Rank 27
EV/saleslower is better7.444.03Rank 26
EV/EBITlower is better34.9321.73Rank 18
Momentum71.4above the middleShare price doing better than the sector: Share price, 6 months 51.63%, sector 24.27%.
MetricStockSector medianPosition in sector
Share price, 1 year8.88%8.66%Rank 51
Share price, 6 months51.63%24.27%Rank 88
Share price, 3 months24.85%15.42%Rank 80
Distance from 52-week high−3.70%−7.35%Rank 67
Quality49.9around the middleQuality about like the sector.
MetricStockSector medianPosition in sector
Accruals (Sloan)lower is better1.12%0.30%Rank 44
Change in share countlower is better−2.41%0.00%Rank 82
Dividend streak in years–10Rank 13
Price reaction to results, market-adjusted1.22%0.05%Rank 60
Balance sheet & risk52.4around the middleRisk about like the sector.
MetricStockSector medianPosition in sector
Equity ratio52.97%48.40%Rank 57
Net debt/EBITDAlower is better0.851.11Rank 56
Debt to equitylower is better0.500.48Rank 50
Volatility, 1 yearlower is better32.71%31.42%Rank 46

Ten years in figures

Revenue from $4.2B (2016) to $6.9B (2025), 5.7% a year.

Fiscal years, amounts in USD
YearRevenue, $BEBIT marginFCFSharesNet debt
20164.214.6%$654.0M329M−$377.0M
20174.518.8%$713.0M326M−$667.0M
20184.918.4%$910.0M325M−$448.0M
20195.218.2%$865.0M318M$1.0B
20205.315.9%$802.0M312M$918.0M
20216.321.3%$1.3B307M$1.2B
20226.823.6%$1.0B300M$1.7B
20236.819.8%$1.5B296M$1.1B
20246.522.9%$1.4B291M$2.2B
20256.921.3%$1.2B284M$1.6B
4.5 / 10Low MatchStockScorer score5 of 11 points

3 of 7 StockScorer Score rules met · How the score is built

Agilent Technologies Inc mainly meets criteria in the Profitability category. Result from 18 strategies checked.

This stock · Profitability: 100%This stock · Growth: 0%This stock · Valuation: 0%This stock · Momentum: 0%Median of all stocks · Profitability: 33%Median of all stocks · Growth: 0%Median of all stocks · Valuation: 0%Median of all stocks · Momentum: 0%50%100%ProfitabilityGrowthValuationMomentumThis stockMedian of all stocks

How Agilent Technologies Inc's score is built

Agilent Technologies Inc is rated here with the StockScorer Score strategy, the flagship rule set. It compares return and cash-flow metrics with the median of the company's own sector and checks growth and price trend.

3 of 7 rules met

5 of 11 points

  1. Free cash flow yield above the sector mediannot met0 of 2 points
  2. Return on capital (Greenblatt ROC) above the sector medianmet2 of 2 points
  3. Return on equity above the sector medianmet1 of 1 point
  4. Free cash flow margin above the sector medianmet2 of 2 points
  5. Revenue growth above 15%not met0 of 2 points
  6. 3-year earnings growth above 12% p.a.not met0 of 1 point
  7. 12-month share price more than 20 percentage points ahead of the marketnot met0 of 1 point
  8. Exclusion: financial and real estate stocksdoes not apply

Detail data

How does Agilent Technologies Inc stock perform across 18 strategies?

Excerpt from 18 strategies checked. The full evaluation is visible after a free sign-up.

12 more strategies locked

With a free account, you can see the match across all strategies checked in one complete overview.

  • Earnings Quality: Accrual Check (Sloan)
  • Growth Momentum (CAN SLIM principle)
  • Defensive: Low Volatility
  • Levermann Strategy (13 Criteria)
  • Undervalued Stocks: Multi-Factor Check
  • Magic Formula: Value + Quality
  • Acquirer's Multiple: EV/EBIT Deep Value
  • Dividend Aristocrats & Continuity
  • Dividend Quality: 4 Factors
  • High-Growth / Rule of 40
  • PEG Strategy (inspired by Peter Lynch)
  • Trending Value: Value + Momentum

Agilent Technologies Inc key metrics: P/E, P/B and equity ratio

Selected fundamental metrics for Agilent Technologies Inc.

MetricStockSector
P/E ratio38.130.0
P/B ratio7.44.8
Return on equity (ROE)19.3%11.5%
Equity ratio53.0%48.4%
Debt-to-equity (D/E)0.500.48
Dividend yield0.6%1.3%

Similar stocks in Healthcare

How comparable stocks in the same sector score in the StockScorer model.

SymbolCompanyRating
AAgilent Technologies Incthis page
NTRANatera Inclocked
IQVIQVIA Holdings IncLow4.5
WATWaters CorporationLow4.5
IDXXIDEXX Laboratories Inclocked
ILMNIllumina Inclocked

Frequently asked questions about Agilent Technologies Inc stock

How does Agilent Technologies Inc stock (A) score in the StockScorer model?
Agilent Technologies Inc stock reaches a StockScorer score of 4.5 out of 10, which is a low match with the rule-based strategies. 3 out of 7 flagship profile rules are met.
What is Agilent Technologies Inc's P/E ratio?
Agilent Technologies Inc's P/E ratio is 38.1. The Healthcare sector median is 30.0.
What sector is Agilent Technologies Inc in?
Agilent Technologies Inc is assigned to the Healthcare sector. Its rank within the sector is 53.0 out of 100: 100 means the stock leads its peer group of large and mid-cap sector stocks in every measured area.

Unlock the full analysis for free

Signed up in 30 seconds, free.

  • More metrics: FCF margin, cash flow yield and more
  • Full peer comparison within the same sector
  • See the match across all strategies in detail
  • Apply your own scoring profile to any stock
  • Add the stock to your watchlist and track score changes
  • Daily updated ratings, rule-based and transparent

Learn more about the metrics in the metrics glossary or all rated stocks in the stock overview.

How StockScorer rates every stock is explained on the methodology page.